These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

41 related items for PubMed ID: 5907951

  • 1. [Iodinated phenoxyalkyl theophylline].
    Kejha J, Rádek O, Nĕmecek O.
    Cesk Farm; 1966 Jan; 15(1):2-4. PubMed ID: 5907951
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Contribution to the study of benzoic acid-theophylline and benzoic acid-paracetamol (author's transl)].
    Mally F, Rivet J, Flahaut J.
    Ann Pharm Fr; 1981 May; 39(1):77-84. PubMed ID: 7247235
    [No Abstract] [Full Text] [Related]

  • 6. [Thermoplastic granulation as an alternative method for the preparation of hydrophilic-lipophilic oral matriix tablets].
    Dvorácková K, Rabisková M, Masteiková R, Vocilková L.
    Ceska Slov Farm; 2007 Jun; 56(3):129-34. PubMed ID: 17867525
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Production of 8-chloro-and 8-bromotheophyllines].
    Khmelevskiĭ VI, Pavlova VV, Durnitsyna OI.
    Med Prom SSSR; 1966 Oct; 20(10):39-40. PubMed ID: 6000059
    [No Abstract] [Full Text] [Related]

  • 12. Physical stability enhancement of theophylline via cocrystallization.
    Trask AV, Motherwell WD, Jones W.
    Int J Pharm; 2006 Aug 31; 320(1-2):114-23. PubMed ID: 16769188
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic use of theophylline to antagonize renal effects of adenosine.
    Osswald H, Gleiter C, Mühlbauer B.
    Clin Nephrol; 1995 Jan 31; 43 Suppl 1():S33-7. PubMed ID: 7781203
    [Abstract] [Full Text] [Related]

  • 14. [Influence of formulation on the rate of theophylline liberation from hydrophilic matrices].
    Masri M, Rodriguez F, Bonnet L, Rouffiac R.
    Ann Pharm Fr; 1984 Jan 31; 42(2):123-34. PubMed ID: 6486658
    [No Abstract] [Full Text] [Related]

  • 15. [Modeling the kinetics of theophylline release from a semi-solid matrix: Gelucire].
    Ortigosa C, Lasserre YJ.
    Ann Pharm Fr; 2003 Nov 31; 61(6):392-8. PubMed ID: 14639191
    [Abstract] [Full Text] [Related]

  • 16. The use of some hydrophobic substances in tablet technology.
    Vitková M, Chalabala M.
    Acta Pharm Hung; 1998 Nov 31; 68(6):336-44. PubMed ID: 9987197
    [Abstract] [Full Text] [Related]

  • 17. [Contrast media. 3. Iodine derivatives of substituted sulfanilamides].
    Rádek O, Kejha J, Nĕmecek O, Kakác B.
    Cesk Farm; 1967 Jan 31; 16(1):34-8. PubMed ID: 6044306
    [No Abstract] [Full Text] [Related]

  • 18. The nonselective adenosine antagonist theophylline does prevent renal dysfunction induced by radiographic contrast agents.
    Kolonko A, Wiecek A, Kokot F.
    J Nephrol; 1998 Jan 31; 11(3):151-6. PubMed ID: 9650124
    [Abstract] [Full Text] [Related]

  • 19. Theophylline formulation by supercritical antisolvents.
    Roy C, Vega-González A, Subra-Paternault P.
    Int J Pharm; 2007 Oct 01; 343(1-2):79-89. PubMed ID: 17582714
    [Abstract] [Full Text] [Related]

  • 20. [Radiological contrast media. XI. Iodized derivatives of alpha-(3-aminomethyl-5-aminobenzoyl) alkanoic acids].
    Felder E, Pitrè D, Fumagalli L.
    Farmaco Sci; 1966 Apr 01; 21(4):295-300. PubMed ID: 5935560
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.